Top Big Data Companies With Best Stability & Growth (2,251)

Strong Revenue Growth: Clearing fee revenue and net income increased sharply in 2025 alongside record contract volumes, and 2026 monthly updates indicate continued double‑digit year‑over‑year activity. These trends point to rising financial throughput consistent with accelerated operating scale.

Market Expansion: The organization began clearing for MIAX Futures in May 2026, extending coverage to 21 exchanges and trading platforms. This broader network signals a widening footprint across venues and products.

Strong Market Position & Advantage: As the sole central counterparty for U.S. listed options and a designated SIFMU, it operates from an entrenched position with unmatched scale. Record multi‑year volumes and substantial risk resources reinforce that advantage.

Strong Revenue Growth: Revenue is accelerating, with FY2025 up 19% year over year and Q4 2025 up 22%, followed by Q1 and Q2 2026 growth of 22% and 27%. Guidance for 2026 was raised to $94–$96 million, implying 22%–24% growth.

Strategic Partnerships: Collaborations with Mount Sinai (April 2026), Memorial Sloan Kettering (June 2026 precision medicine hub), and an expanded AstraZeneca alliance (August 2025) are highlighted as supporting platform adoption and data generation. Several large BioPharma contracts signed into late 2025/early 2026 further reinforce traction.

Customer Loyalty & Retention: Spending within the installed base is rising, with net dollar retention improving to 115% in 2025 and 117% in the first quarter of 2026. This coincides with rising analysis volumes across 2025–2026.

Profitability: Profit metrics and margins are rising in 2026, with Q2 EBIT‑adjusted up ~30% to $3.94B and the margin improving to 8.2%, alongside a first‑half margin of 8.9%. Management also raised full‑year 2026 profit guidance to $14–$16B, reflecting stronger earnings power driven by mix, pricing, and cost discipline.

Healthy Cash Flow: Adjusted automotive free cash flow grew sharply (up 78% in Q2 and 73% year to date), and the company reinforced confidence by declaring a $0.18 quarterly dividend and authorizing a $6B buyback. These capital returns accompany higher full‑year free‑cash‑flow guidance of $9.5–$11.5B.

Diversified Revenue Streams: Software‑enabled services and subscriptions are contributing more meaningfully, with roughly 620,000 subscribers, $5.4B of deferred revenue at 2025 year‑end, and OnStar revenue up ~20% year over year in Q2 2026. The company indicates software revenue is on track to exceed $3B in 2026.

Strong Market Position & Advantage: Leadership positions across biscuits (#1) and chocolate (#2), anchored by iconic brands and a presence in 150+ countries, support pricing power and distribution reach. Category and geographic breadth are cited as underpinning mid‑term growth capacity.

Resilient & Sustainable Growth: Net revenues and organic net revenue increased in 2025 and remained positive into 2026 despite a tougher cost environment and moderating pace. Management signals potential to reaccelerate profitable growth as cocoa costs stabilize and productivity programs take hold.

Healthy Cash Flow: Guidance for 2026 targets approximately $3 billion in free cash flow, alongside maintained capital returns such as a dividend increase. This cash generation supports continued reinvestment behind brands and execution.

Strategic Partnerships: Partnerships with Quest Analytics (June 16, 2025) and collaborations such as with the American College of Surgeons, alongside a growing Aggregate user conference in 2025–2026, align with commercial momentum. Announced marketplace additions and ecosystem integrations further point to an expanding partner network.

Investor Backing & Capital Strength: Nordic Capital became the majority owner in July 2025 to support a “next phase of growth,” building on a $125 million financing from Vista Credit Partners in 2023. These moves signal access to capital to scale the platform and accelerate expansion.

Product Line Growth: A next‑gen lakehouse‑based data platform launched in February 2024 and subsequent 2025–2026 AI/interoperability capabilities—building on the CareJourney acquisition—indicate continued product expansion. New solutions such as Network Modeler and Contract IQ are cited as part of this cadence.

Diversified Customer Base: Customer count expanded from more than 1,200 brands in 2023 to 1,600+ by 2026, indicating broader adoption across regions and modes.

Innovation-Driven Growth: Multiple 2026 launches—Loft AI, Inventory Twin enhancements, and an agentic ocean booking platform—signal an active roadmap and continued go‑to‑market motion.

Strong Market Position & Advantage: Being named a Leader in Gartner’s 2024 Magic Quadrant for RTTVPs reflects established competitive standing heading into 2025.

Strong Market Position & Advantage: Independent market-share analysis places Celonis at the front of its category while the market itself expands. This positioning suggests the company is capturing growth in a segment it leads.

Future-Ready Strategy: External recognition for long-term growth potential signals confidence in Celonis’s strategy, innovation, and talent pipeline. This points to preparedness as the space broadens from process mining into process intelligence and AI-enabled workflows.

Strategic Partnerships: A new alliance with a major data and AI platform provider expands product integrations and go-to-market reach into enterprise AI workflows. Such ecosystem momentum supports broader adoption and commercial expansion.

Resilient & Sustainable Growth: Growth is described as measured and predictable, with signals such as modest headcount expansion, sustained operating scale, and continued momentum rather than volatility.

Innovation-Driven Growth: Recent major releases across IRIS/IRIS for Health/Health Connect and new AI-focused offerings indicate ongoing R&D velocity that broadens capabilities and use cases.

Strong Market Position & Advantage: Repeated industry accolades for Shared Care Records/HIE and regional acute EHRs in 2026 point to durable competitive standing in core healthcare markets.

Profitability: The company is described as profitable and bootstrapped with $100M+ cumulative revenue, with leadership materials citing roughly $22M in annual revenue. Feedback suggests this footing enables continued investment and operating resilience without relying on external capital.

Innovation-Driven Growth: The 2026 rebrand to Product.ai, launch of a “truth layer for commerce” and Axiomatic Intelligence, and rollouts across new categories and agent endpoints indicate an active product push. Feedback suggests ongoing research publications and a visible founder narrative support a category-creation strategy.

Strong Hiring & Retention: Recent postings for a Founding Product Lead and multiple senior roles in AI/ML, revenue systems, and commercial functions signal headcount expansion. Feedback suggests the organization is scaling product, engineering, and go-to-market capacity.

Strong Revenue Growth: Recent results show revenue up 9.6% year over year in Q2 2026 (6.8% organic; 8.2% excluding product sunsets), with 2025 up 7.5% and year‑to‑date 2026 up 10.2% on a reported basis. Growth is led by Morningstar Credit and core data/software platforms such as Morningstar Direct and PitchBook.

Profitability: Operating and adjusted operating margins expanded in Q2 2026 alongside a 29% rise in adjusted diluted EPS to $3.10, and 2025 saw increases in operating income and adjusted operating income. These gains were supported by stronger contribution from Credit and the accretive effect of the CRSP acquisition.

Healthy Cash Flow: Free cash flow and operating cash flow increased sharply in Q2 2026, with free cash flow nearly doubling year over year. This improved cash generation coincided with active buybacks and dividends.

Strong Revenue Growth: Revenue rose from $69 million in 2024 to $101 million in 2025, with late-2025/early-2026 annualized run rate reportedly surpassing $125–$130 million, signaling renewed momentum. This trajectory aligns with rising borrower counts in 2025.

Profitability: The company achieved its first annual net profit in 2025 (about $3 million), indicating improved unit economics and financial discipline. This marks a shift from prior pandemic-era stagnation.

Market Expansion: Loans expanded to roughly 33–34 states in 2025, including 19 new state launches, and support materials updated in mid-2026 indicate active operations. Customer reach increased to about 700,000 unique loan recipients in 2025.

Strong Revenue Growth: Company communications describe ARR more than tripling in 2025, marking its strongest year to date. These disclosures point to clear top‑line momentum into 2026.

Product Line Growth: Announcements highlight expanded AI functionality for healthcare in June 2026 alongside ongoing platform updates. This indicates continued investment in new capabilities and vertical depth.

Strong Hiring & Retention: Multiple senior appointments in mid‑2026, including an EVP of Technology & Operations and additional leadership roles, suggest active scaling of the executive and technical bench. References to broader team expansion reinforce organizational build‑out.

Investor Backing & Capital Strength: Recent funding from Blackstone Growth—$100 million in January 2026 at a reported $500–700 million valuation—signals strong external confidence and provides runway to scale. Company communications describe the capital as intended to fuel continued growth at scale.

Strong Revenue Growth: Multiple recent job postings describe revenue up roughly 10x over the last four years, reflecting a fast-growth trajectory. These statements frame the business as expanding rapidly across its core offerings.

Strong Hiring & Retention: Company materials and LinkedIn indicate the team grew to more than 200 employees in 2025 with headcount up nearly 5x over four years, and the listed company-size band of 201–500 suggests ongoing expansion. Active hiring posts reinforce that scaling is underway.

Investor Backing & Capital Strength: Recent financing includes a sizable equity round co-led by well-known investors alongside a credit facility, providing resources to expand products and underwriting capabilities. Public announcements frame this capital as fuel to scale the platform for life and annuity carriers.

Strategic Partnerships: Collaborations with large carriers are highlighted for accelerating launches and improving application completion, indicating the platform is delivering measurable impact within established insurers. Named programs with marquee brands reinforce credibility and access to enterprise distribution.

Strong Revenue Growth: Company communications describe rapid ARR and revenue expansion over multiple years since the pivot to a software platform. Reported momentum aligns with increased transaction activity and broader platform adoption across carriers.

Innovation-Driven Growth: Product launches such as AI Search Lift and ongoing rollouts of Brand Lift, Outcomes Lift, and cookieless measurement point to active R&D and continued expansion of capabilities.

Strategic Partnerships: Recent agreements with partners like DAX US for audio measurement and selections by large media owners (e.g., Comcast Advertising, Vevo, Warner Bros. Discovery) signal expanding distribution and commercial traction.

Future-Ready Strategy: Positioning around cross-platform, cookieless, and AI-aware measurement, alongside regular industry research and benchmarks, indicates alignment with post-cookie and AI-era advertiser needs.

Strong Revenue Growth: Management disclosed 11 consecutive quarters of top-line expansion as of Q2 2026, with guidance indicating continued increases post‑IPO. Observations across filings and coverage describe multi‑quarter momentum rather than a one‑off spike.

Investor Backing & Capital Strength: A completed IPO and a prior minority investment from General Atlantic alongside Blackstone signal institutional confidence and provide balance‑sheet flexibility. Proceeds were used in part to reduce debt, supporting capacity for further expansion.

Innovation-Driven Growth: The Cortex AI platform is presented as a core differentiator driving performance gains across a unified DSP/SSP stack. Product updates and shortened learning cycles are highlighted as catalysts for advertiser and publisher adoption.

Innovation-Driven Growth: Regulatory momentum is evident with FDA 510(k) clearance for the eVO2peak Module and references to multiple FDA-cleared algorithms, alongside ISO 13485 and MDSAP certifications. Ongoing clinical activity and datasets (e.g., OCORO Heart Study, multi‑million hours of heart data) point to a steadily expanding product and evidence base.

Strategic Partnerships: The March 27, 2025 acquisition by Kardigan integrates Prolaio’s FDA‑cleared software, curated CV datasets, and analytics into a larger R&D platform, signaling added resources and scope. Materials indicate Prolaio continues operating independently while benefiting from Kardigan’s broader heart‑health strategy.

Strong Hiring & Retention: Hiring signals are visible through an active careers page, a stated 32 new hires in 2025, and multiple current openings across functions. Employer recognition such as “Best Places to Work 2026” and ongoing recruiting activity suggest team expansion and brand momentum.

Investor Backing & Capital Strength: A $70M Series C announced on May 28, 2025 and the April 30, 2025 acquisition of Hashboard signal substantial resources and scale-up momentum. These moves indicate ample runway to fund product development and go-to-market execution.

Strategic Partnerships: Recognition at Snowflake Summit 2026 as Product Partner of the Year for Agentic Analytics and deep Snowflake integrations point to strong ecosystem alignment. This partner-led motion can accelerate adoption within a key data cloud.

Product Line Growth: Since late 2024 the company has shipped new capabilities (e.g., Explore drag-and-drop analytics; enhanced AI/agent features like Agent Observability) and expanded into BI via the Hashboard acquisition. A visible 2025–2026 release cadence suggests active investment and a broader user footprint.

Strong Revenue Growth: Total revenue increased 19% in FY2026 and 16% in Q1 FY2027, while ARR reached about $2.14B, up roughly 17% year over year. Net‑new ARR also accelerated, signaling strengthening demand.

Profitability: Non‑GAAP operating income was $592M in FY2026 with ~29% margin, and Q1 FY2027 reported a ~29% margin alongside robust adjusted free cash flow. Free cash flow for FY2026 was $529M, underscoring strong operating leverage.

Resilient & Sustainable Growth: Multi‑year double‑digit ARR and revenue expansion, record large deals, and 41% organic net‑new ARR growth in Q1 FY2027 point to durable demand. A subscription‑led model and fast‑growing logs consumption support ongoing platform adoption.

Resilient & Sustainable Growth: Advertising & subscription revenues attributed to Edmunds rose steadily from $133.3M (FY2023) to $144.5M (FY2026), with a further 3.7% increase in FY2026 pointing to durable, low‑single‑digit momentum. This multi‑year pattern indicates consistent, measured expansion rather than volatility.

Strong Brand Reputation: Edmunds is repeatedly characterized as a prominent, trusted leader in automotive research and pricing intelligence, with expert testing and widely cited market analyses underpinning its credibility. This standing supports continued relevance with consumers, OEMs, and dealers.

Strategic Partnerships: Dealer/OEM channel integrations expanded with GM IMR Turnkey approval for trade‑in and instant‑offer tools, and brand programs like the 2025 LA Dodgers campaign broadened reach. These partnerships signal active routes to distribution and monetization beyond owned channels.